Skip to main content
Premium Trial:

Request an Annual Quote

Genomatix Gets $500K in Series B Private Equity Round

NEW YORK, May 18 (GenomeWeb News) - Genomatix, a Roanoke, Va.-based gene expression and proteomics tools company, today announced that it has closed a Series B round of financing led by a $500,000 investment from NewVa Capital Partners, a venture capital fund managed by Third Security.

 

Robert Beech, CEO of Genomatix, said in a statement that the new funding will "accelerate the roll out and marketing of its proprietary genetic tools," and called NewVa's investment a "strong indicator" that the company was on the "right track, both scientifically and commercially."

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.